Daclatasvir plus asunaprevir for <scp>HCV</scp> genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
Jia‐Horng Kao(National Taiwan University Hospital), Stephanie Noviello(Novartis (United States)), Eric Hughes(The University of Texas at San Antonio Health Science Center), Rafia Bhore(Bristol-Myers Squibb (Germany)), Fernando Bessone(National University of Rosario), Jeong Heo(National Cancer Center), Patricia Méndez, Cheng‐Yuan Peng(China Medical University), William Sievert(Monash Health), Ira M. Jacobson(Cornell University), Boris Yoffe(Baylor College of Medicine), Hiromitsu Kumada(Toranomon Hospital), Joji Toyota(Sapporo Kosei General Hospital), Youn‐Jae Lee(Inje University Busan Paik Hospital), Michael P. Manns(Medizinische Hochschule Hannover), Donald M. Jensen(Rush University Medical Center), Stuart K. Roberts(The Alfred Hospital)
Cited by 16
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
|New England Journal of Medicine|2020|1.8k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k